Category

Clinical Trials

Mene Pangalos

COVID-19 vaccine showed robust immune responses in all participants

July 20, 2020

Interim results from the ongoing …

AstraZeneca scientist

AstraZeneca announces results from Phase III ETHOS trial

July 14, 2020

Full results from the positive …

GeNeuro and Karolinska Institutet enrolls first patient in Phase 2 trial

July 13, 2020

GeNeuro enrolls first patient in …

Nordic Nanovector

Nordic Nanovector to amend trial protocol

July 2, 2020

Nordic Nanovector will amend the …

Gesynta Pharma team

Promising results from Gesynta Pharma

June 19, 2020

Gesynta Pharma reports positive Phase …

Novo Nordisk CMC Development

Novo Nordisk announces Phase 2 results

June 16, 2020

Novo Nordisk announced results from …

Klaas Bakker

Positive results from Oncopeptides

June 16, 2020

Oncopeptides has announced that the …

Alex Karlsson Parra

Immunicum advances its Phase Ib/II combination trial

June 15, 2020

Immunicum has announced that the …

Fredrik Frejd

Affibody terminates program and announces positive data from another

June 15, 2020

Affibody has announced the completion …

AstraZeneca Södertälje

AstraZeneca to supply Europe with up to 400 million vaccine doses

June 15, 2020

AstraZeneca has reached an agreement …

Martin Jönsson

AlzeCure announces positive data

June 5, 2020

AlzeCure Pharma has received positive …

Clinical trial

Follicum re-starts phase II study

June 4, 2020

Follicum has announced that the …

BerGenBio Photo Nils Olav Mevatne

First COVID-19 patient dosed with bemcentinib

June 3, 2020

BerGenBio has announced that dosing …

AstraZeneca scientist

Positive trial results from AstraZeneca

June 3, 2020

The pharma company has lately …

Jakob Lindberg

Oncopeptides completes Phase 3 study enrollment

June 3, 2020

Oncopeptides has announced completion of …

Sara Gunnerås

New report: Sweden’s drug development pipeline

June 2, 2020

The Swedish life science industry …

1
2
3
···
30